tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NMRA Stock Latest News

Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair
The FlyNeumora Therapeutics downgraded to Market Perform from Outperform at William Blair
18d ago
NMRA
Johnson & Johnson discontinues depression program for aticaprant
PremiumThe Fly
Johnson & Johnson discontinues depression program for aticaprant
19d ago
JNJ
NMRA
Douglas Tsao Recommends ‘Buy’ for Neumora Therapeutics Due to Navacaprant’s Market Potential and Differentiated Pharmacology
PremiumRatings
Douglas Tsao Recommends ‘Buy’ for Neumora Therapeutics Due to Navacaprant’s Market Potential and Differentiated Pharmacology
19d ago
NMRA
Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim
19d ago
JNJ
NMRA
Cautious Hold Rating on Neumora Therapeutics Amid Efficacy Concerns and Clinical Trial Setbacks
PremiumRatings
Cautious Hold Rating on Neumora Therapeutics Amid Efficacy Concerns and Clinical Trial Setbacks
19d ago
NMRA
Neumora Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe FlyNeumora Therapeutics downgraded to Hold from Buy at Stifel
19d ago
JNJ
NMRA
Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays
Premium
Ratings
Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays
22d ago
NMRA
Neumora Therapeutics price target lowered to $18 from $30 at H.C. Wainwright
Premium
The Fly
Neumora Therapeutics price target lowered to $18 from $30 at H.C. Wainwright
22d ago
NMRA
Neumora Therapeutics Reports 2024 Financial Results and Updates
PremiumCompany Announcements
Neumora Therapeutics Reports 2024 Financial Results and Updates
22d ago
NMRA
Neumora Therapeutics Earnings Call: Balancing Growth and Challenges
PremiumCompany Announcements
Neumora Therapeutics Earnings Call: Balancing Growth and Challenges
22d ago
NMRA
Strategic Adjustments and Future Prospects Drive Buy Rating for Neumora Therapeutics
PremiumRatings
Strategic Adjustments and Future Prospects Drive Buy Rating for Neumora Therapeutics
22d ago
NMRA
Neumora Therapeutics price target lowered to $6 from $26 at Stifel
PremiumThe Fly
Neumora Therapeutics price target lowered to $6 from $26 at Stifel
23d ago
NMRA
Morning Movers: Coinbase and Robinhood jump after Trump announces crypto reserve
PremiumThe FlyMorning Movers: Coinbase and Robinhood jump after Trump announces crypto reserve
23d ago
ALGM
COIN
Neumora Therapeutics expects cash to fund operations into mid-2026
Premium
The Fly
Neumora Therapeutics expects cash to fund operations into mid-2026
23d ago
NMRA
Neumora Therapeutics reports Q4 EPS (37c), consensus (44c)
Premium
The Fly
Neumora Therapeutics reports Q4 EPS (37c), consensus (44c)
23d ago
NMRA
Neumora Therapeutics, Inc. (NMRA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Neumora Therapeutics, Inc. (NMRA) Q4 Earnings Cheat Sheet
25d ago
NMRA
Neumora Therapeutics price target lowered to $4 from $20 at Mizuho
PremiumThe Fly
Neumora Therapeutics price target lowered to $4 from $20 at Mizuho
29d ago
NMRA
Positive Prospects for Neumora Therapeutics: Buy Rating Supported by Leadership Change and Strategic R&D Focus
PremiumRatings
Positive Prospects for Neumora Therapeutics: Buy Rating Supported by Leadership Change and Strategic R&D Focus
1M ago
NMRA
Neumora Therapeutics Announces Leadership Changes and Strategy
PremiumCompany Announcements
Neumora Therapeutics Announces Leadership Changes and Strategy
1M ago
8K
NMRA
Neumora Therapeutics appoints Berns as CEO, chairman of board
PremiumThe FlyNeumora Therapeutics appoints Berns as CEO, chairman of board
1M ago
NMRA
Levi & Korsinsky LLP Reminds Shareholders of a Lead Plaintiff Deadline of April 07, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA
Premium
Class Action
Levi & Korsinsky LLP Reminds Shareholders of a Lead Plaintiff Deadline of April 07, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA
2M ago
NMRA
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
BSX
MPW

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >